Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Kane Biotech Inc V.KNE

Alternate Symbol(s):  KNBIF

Kane Biotech Inc. is a Canada-based biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and remove microbial biofilms. The Company has a portfolio of biotechnologies, intellectual property (66 patents and patents pending, trade secrets and trademarks) and products developed by its own biofilm research expertise and acquired... see more

TSXV:KNE - Post Discussion

Kane Biotech Inc > New Press Release - Kane Biotech Signs Worldwide License Agreement with Omni Bioceutical Innovations Inc.
View:
Comment by RoyMax123 on Jul 11, 2024 8:35am
Things start to move, I like that it's non exclusive agreement.
Comment by francoisl13 on Jul 11, 2024 10:56am
The news title is a little misleading...''worldwide license agreement'', when looking at the OMNI Bioceutical website, it is clear that they only sell in the USA so, that alone explains why it is a non-exclusive agreement. On the other side, it is a first license for a DermaKB product so, things are moving forward. As noted before, this is a well managed company with good ...more  
Comment by RoyMax123 on Jul 11, 2024 12:01pm
Or they are doing like Kane and have partnership in other country that sell their products under their own brand name. 
Comment by francoisl13 on Jul 11, 2024 12:07pm
From the OMNI Bioceutical Innovations website FAQ's section; ''At this time we do not ship internationally. If you are an international skin health professional and are interested in carrying our products please contact us at (888) 578-3335''
Comment by RoyMax123 on Jul 11, 2024 12:23pm
Yes, but that only mean that  they do not ship worldwide themself. Look at that PDF https://venturemadness.com/wp-content/uploads/2017/01/Omni-Bioceutical-Innovations-Inc.pdf In the part 3 "Omni has been approached by and has signed NDAs with three worldwide industry leaders for unique products that will be supported through their client’s distribution network"  So they ...more  
Comment by francoisl13 on Jul 11, 2024 3:01pm
Nice find Roymax123 and thanks for sharing. The document is little out-dated (ie.2017) so, we don't know if they are still following the same path to market, if the deal are still in effect or not, etc...especially after the world went through Covid but it shows that OMNI had an 'outside of the USA' back in 2017. As you said, let's hope for Mr. Edwards to shed some light on this ...more  
Comment by lscfa on Jul 14, 2024 9:19pm
At least expand to English speaking countries where minimal changes to packaging are required.
Comment by MirrorWorldMan on Jul 14, 2024 6:15pm
Nice to get street Cred with Coactiv+ scalp and hopefully some revenues at a time when debts are getting paid off. Cash burn has been traditionally high, operating revenue is paramount. 
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities